EA201891337A3 - Фармацевтическая композиция от нейропатической боли - Google Patents

Фармацевтическая композиция от нейропатической боли

Info

Publication number
EA201891337A3
EA201891337A3 EA201891337A EA201891337A EA201891337A3 EA 201891337 A3 EA201891337 A3 EA 201891337A3 EA 201891337 A EA201891337 A EA 201891337A EA 201891337 A EA201891337 A EA 201891337A EA 201891337 A3 EA201891337 A3 EA 201891337A3
Authority
EA
Eurasian Patent Office
Prior art keywords
neuropathic pain
pharmaceutical composition
composition
application
pea
Prior art date
Application number
EA201891337A
Other languages
English (en)
Other versions
EA035667B1 (ru
EA201891337A2 (ru
Inventor
Анкит Шиам Сингх
Ведпракаш Мишра
Неелима Тонгра
Original Assignee
Фримлайн Прайвет Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фримлайн Прайвет Лимитед filed Critical Фримлайн Прайвет Лимитед
Publication of EA201891337A2 publication Critical patent/EA201891337A2/ru
Publication of EA201891337A3 publication Critical patent/EA201891337A3/ru
Publication of EA035667B1 publication Critical patent/EA035667B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В настоящей заявке описана фармацевтическая композиция/состав для применения в борьбе с нейропатической болью. Композиция/состав содержит пальмитоилэтаноламид (ПЭА) и один или более натуральных ингредиентов. В заявке также представлены различные составы и способы их получения.
EA201891337A 2017-07-05 2018-07-03 Фармацевтическая композиция от нейропатической боли EA035667B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201721023668 2017-07-05

Publications (3)

Publication Number Publication Date
EA201891337A2 EA201891337A2 (ru) 2019-01-31
EA201891337A3 true EA201891337A3 (ru) 2019-05-31
EA035667B1 EA035667B1 (ru) 2020-07-23

Family

ID=61691848

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201891337A EA035667B1 (ru) 2017-07-05 2018-07-03 Фармацевтическая композиция от нейропатической боли

Country Status (19)

Country Link
US (1) US20190008806A1 (ru)
EP (1) EP3424499B1 (ru)
BR (1) BR102018013710A2 (ru)
CA (1) CA2999030C (ru)
CY (1) CY1122829T1 (ru)
DK (1) DK3424499T3 (ru)
EA (1) EA035667B1 (ru)
ES (1) ES2776879T3 (ru)
HR (1) HRP20200328T1 (ru)
LT (1) LT3424499T (ru)
ME (1) ME03680B (ru)
MY (1) MY172113A (ru)
PH (1) PH12018000077A1 (ru)
PL (1) PL3424499T3 (ru)
PT (1) PT3424499T (ru)
RS (1) RS60127B1 (ru)
SG (1) SG10201802129QA (ru)
SI (1) SI3424499T1 (ru)
UA (1) UA122080C2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023133555A2 (en) * 2022-01-10 2023-07-13 Zilker Sciences Llc Palmitoylethanolamide treatment for covid-19-related inflammation
EP4331577A1 (en) * 2022-08-30 2024-03-06 Unifarco S.p.A. A nutraceutic tablet comprising palmitoylethanolamide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101063663B1 (ko) * 2005-02-17 2011-09-07 아스텔라스세이야쿠 가부시키가이샤 피리딜 비방향족 질소 함유 헤테로환-1-카르복실산에스테르유도체
ITPD20050224A1 (it) * 2005-07-19 2007-01-20 Actimex Srl Composizioni contenenti micronutrienti aventi in particolare attivita' antiossidante e loro impiego
US20080089845A1 (en) * 2006-09-07 2008-04-17 N.V. Organon Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo
CA2727245A1 (en) * 2008-06-11 2009-12-17 Merck Sharp & Dohme Corp. Imidazole derivatives useful as inhibitors of faah
EP2334202B1 (en) * 2008-09-04 2012-02-01 Cargill, Incorporated Tabletting of ervthritol
PT2796129E (pt) * 2009-09-07 2015-10-13 Epitech Group S P A Composição contendo palmitoiletanolamida ultramicronizada
WO2013121449A1 (en) * 2012-02-17 2013-08-22 Epitech Group S.R.L. Compositions and methods for the modulation of specific amidases for n-acylethanolamines for use in the therapy of inflammatory diseases
NL2014464B1 (en) * 2015-03-16 2017-01-13 Vanderbilt Science Holding Ltd Composition for use in the treatment of neuropathic pain.
WO2016183134A1 (en) * 2015-05-12 2016-11-17 Cutting Edge Medical Solutions, Llc Palmitoylethanolamide compositions
ITUB20153066A1 (it) * 2015-08-11 2017-02-11 Graal S R L Composizione alimentare e/o nutraceutica contenente pea

Also Published As

Publication number Publication date
CA2999030C (en) 2019-10-29
CA2999030A1 (en) 2019-01-05
LT3424499T (lt) 2020-03-25
SI3424499T1 (sl) 2020-06-30
EP3424499B1 (en) 2019-12-25
EA035667B1 (ru) 2020-07-23
PT3424499T (pt) 2020-03-31
PH12018000077B1 (en) 2019-01-21
HRP20200328T1 (hr) 2020-07-24
SG10201802129QA (en) 2019-02-27
US20190008806A1 (en) 2019-01-10
CY1122829T1 (el) 2021-05-05
BR102018013710A2 (pt) 2019-01-22
DK3424499T3 (da) 2020-03-23
MY172113A (en) 2019-11-14
PL3424499T3 (pl) 2020-06-29
EP3424499A1 (en) 2019-01-09
PH12018000077A1 (en) 2019-01-21
EA201891337A2 (ru) 2019-01-31
ES2776879T3 (es) 2020-08-03
UA122080C2 (uk) 2020-09-10
ME03680B (me) 2020-10-20
RS60127B1 (sr) 2020-05-29

Similar Documents

Publication Publication Date Title
PH12020550051A1 (en) Glp-1 compositions and uses thereof
SV2018005643A (es) Composiciones de insulina de rapida accion
WO2016060996A3 (en) Interleukin-15 compositions and uses thereof
EA201790787A1 (ru) Снижение вязкости фармацевтических составов
CL2016002389A1 (es) Compuestos derivados de amidopiridina, agonista inverso del receptor cannabinoide tipo 2 composicion farmaceutica procedimiento de preparación y uso de los compuestos en el tratamiento o profilaxis del dolor neuropatico, asma, osteoporosis, inflamacion, entre otros.
MX2020001885A (es) Formulaciones de daptomicina.
MX2020008125A (es) Composiciones que comprenden berberina.
MX2023001963A (es) Composiciones farmaceuticas hipertonicas que contienen un agente quimioprotector antiplatino.
AU2019363725B2 (en) Stable semaglutide compositions and uses thereof
EA202091095A1 (ru) Пероральная доставка пептидных аналогов glp-1
MX2019004580A (es) Formulaciones farmaceuticas y metodos para prepararlas.
PH12018502540A1 (en) Formulations of polyalkylene oxide-asparaginase and methods of making and using the same
JO3565B1 (ar) الأجسام المضادة لشبيه الأنجيوبوييتين– 4 وطرق استخدامها
EA201891337A3 (ru) Фармацевтическая композиция от нейропатической боли
WO2016015055A8 (en) Colon cleansing compositions
PH12020551618A1 (en) Erenumab compositions and uses thereof
EA201892376A1 (ru) Комбинированный состав трех противовирусных соединений
MX2021005910A (es) Formulacion de proteina de alta concentracion.
MY186286A (en) A pharmaceutical composition for improving or preventing progression of chronic kidney disease
EA202191515A1 (ru) Фармацевтическая композиция, содержащая апиксабан
MX2021006488A (es) Composiciones para mejorar la funcion sexual.
MX2017013879A (es) Composiciones que comprenden anakinra.
MX2020013684A (es) Formulaciones/composiciones que comprenden ibrutinib.
EP3829643C0 (en) SYNERGISTIC COOPERATIVE COMPOSITIONS FOR SOFT TISSUE AUGMENTATION, DRUG DELIVERY AND RELATED AREAS
EA202090971A1 (ru) Способы применения и композиции, содержащие дулаглутид